IAIM
XERS icon

International Assets Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

International Assets Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,435
Closed -$11K – 1932
2021
Q1 		$11K Buy
2,435
+1,435
+144% +$7.74K ﹤0.01% 1541
2020
Q4 		$5K Buy
+1,000
New +$5K ﹤0.01% 1667

Other funds holding XERS

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

International Assets Investment Management's XERS Position: Q2 2021 in Review

International Assets Investment Management sold out of Xeris Biopharma Holdings (XERS) in Q2 2021, closing a stake of 2,435 shares — an estimated $11K sold.

International Assets Investment Management first reported a position in XERS in Q4 2020 and held it in 2 quarters. The position peaked at $11K in Q1 2021. 93 funds tracked by Wall St. Rank hold XERS as of Q2 2021.

  • International Assets Investment Management reported no remaining Xeris Biopharma Holdings position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 2,435 Xeris Biopharma Holdings shares in Q2 2021, an estimated $11K.
  • International Assets Investment Management first reported a position in Xeris Biopharma Holdings in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Xeris Biopharma Holdings position peaked at $11K in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.